Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemokines in Primary Liver Cancer. | Int J Mol Sci | 2022 | 36012108 | PubTator, text mining | PubMed |
| Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain. | ACS Omega | 2022 | 35991504 | PubTator, text mining | PubMed |
| Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis. | Diab Vasc Dis Res | 2022 | 35989592 | PubTator, text mining | PubMed |
| Subphenotypes in acute kidney injury: a narrative review. | Crit Care | 2022 | 35986336 | PubTator, text mining | PubMed |
| Serological biomarkers in autoimmune GFAP astrocytopathy. | Front Immunol | 2022 | 35983033 | PubTator, text mining | PubMed |
| Swapping N-terminal regions among tick evasins reveals cooperative interactions influencing chemokine binding and selectivity. | J Biol Chem | 2022 | 35973511 | PubTator, text mining | PubMed |
| CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid plaque. | J Stroke Cerebrovasc Dis | 2022 | 35973397 | PubTator, text mining | PubMed |
| Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors. | J Exp Clin Cancer Res | 2022 | 35971164 | PubTator, text mining | PubMed |
| A successful repair of pentacuspid aortic valve. | JTCVS Tech | 2022 | 35967234 | PubTator, text mining | PubMed |
| Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway. | J Ethnopharmacol | 2022 | 35964820 | PubTator, text mining | PubMed |
| Identification of HMGB2 associated with proliferation, invasion and prognosis in lung adenocarcinoma via weighted gene co-expression network analysis. | BMC Pulm Med | 2022 | 35962344 | PubTator, text mining | PubMed |
| Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice-A Mechanistic Systematic Review. | Int J Mol Sci | 2022 | 35955751 | PubTator, text mining | PubMed |
| A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma. | Cancers (Basel) | 2022 | 35954390 | PubTator, text mining | PubMed |
| Peripheral gene interactions define interpretable clusters of core ASD genes in a network-based investigation of the omnigenic theory. | NPJ Syst Biol Appl | 2022 | 35948596 | PubTator, text mining | PubMed |
| Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer. | Front Immunol | 2022 | 35935996 | PubTator, text mining | PubMed |
| Receptor-ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing. | Front Immunol | 2022 | 35935973 | PubTator, text mining | PubMed |
| CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis. | Front Immunol | 2022 | 35935945 | PubTator, text mining | PubMed |
| Staphylococcus aureus lineages associated with a free-ranging population of the fruit bat Pteropus livingstonii retained over 25 years in captivity. | Sci Rep | 2022 | 35931727 | PubTator, text mining | PubMed |
| Alteration of the Oligodendrocyte Lineage Varies According to the Systemic Inflammatory Stimulus in Animal Models That Mimic the Encephalopathy of Prematurity. | Front Physiol | 2022 | 35928559 | PubTator, text mining | PubMed |
| Evidence for Monocyte Reprogramming in a Long-Term Postsepsis Study. | Crit Care Explor | 2022 | 35928539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=36